Clinical Development Containment DNA Life Science 
XTalks
NOVEMBER 6, 2020
The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid. Related: Red Meat Allergy Test Gets FDA Clearance. “We
Delveinsight
JULY 29, 2020
The Government of India in order to contain the spread of novel coronavirus rolled out several guidelines and precautionary measures. Zydus has started the human clinical trials of its plasmid DNA based vaccine, ZyCoV-D. USA to develop Covid-19 vaccine, through a Joint Venture company to be based in Ireland.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
JANUARY 19, 2024
Radiobiological and Clinical Considerations from CRO and Emerging Biotech Radiopharmaceuticals are medicinal formulations containing radioisotopes that are used in the field of nuclear medicine primarily for the diagnosis and treatment of various diseases, particularly cancer. In addition, the cascades can also contain beta emissions.
XTalks
AUGUST 2, 2023
It contains the antiviral medications nirmatrelvir and ritonavir. It works by containing lymphocytes within the lymph nodes , preventing them from entering the central nervous system via the blood-brain barrier and causing an autoimmune reaction that destroys myelin on neurons. Pfizer’s total global revenue from Paxlovid was $18.93
XTalks
OCTOBER 26, 2023
Kierstead joined PPD in 2009 and is currently an executive director of the vaccine sciences lab. She has 23 years of experience working with clients to move vaccine candidates through the clinical development pipeline, including regulatory submission. It worked in the favor of vaccine makers that X.BB.1.5
Drug Discovery World
NOVEMBER 30, 2023
Lonza’s integrated CMC strategy and timeline was presented, as well as case studies highlighting key approaches and technologies, including: vector design & integration, cell line selection, downstream process, analytical method and formulation development. kb Influenza A hemagglutinin gene was used as a model system.
XTalks
FEBRUARY 3, 2021
Johnson & Johnson’s single-shot DNA vaccine candidate was shown to have an overall effectiveness of 66 percent in preventing moderate to severe COVID-19. Johnson & Johnson’s DNA Vaccine. The DNA vaccine was created using Janssen’s AdVac technology platform that is designed for rapid vaccine development.
Expert insights. Personalized for you.
75 
Let's personalize your content